Scientists present current evidence for a new gene therapy for Duchenne muscular dystrophy called delandistrogene moxeparvovec.
Categories
Recent Posts
- Your Guide to Genetic Testing for Neuromuscular Diseases
- Finding balance while parenting children with DMD can be tricky
- Finding harmony and inclusion in life through music
- CureDuchenne’s latest investment aims to address the limitations of current AAV-delivered gene therapy treatments for Duchenne muscular dystrophy (DMD).
- Elevidys halted in nonambulatory DMD after second death reported